Citadel Advisors
OPRX icon

Citadel Advisors’s OptimizeRx OPRX Stock Holding History

Citadel Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$904K Buy
+157,992
New +$908K ﹤0.01% 8453
2026
Q1 		– Sell
-11,976
Closed -$111K – 13868
2025
Q4 		$147K Sell
11,976
-96,815
-89% -$1.58M ﹤0.01% 11340
2025
Q3 		$2.23M Sell
108,791
-73,555
-40% -$1.17M ﹤0.01% 5858
2025
Q2 		$2.46M Buy
182,346
+110,471
+154% +$1.21M ﹤0.01% 5333
2025
Q1 		$622K Buy
71,875
+30,826
+75% +$188K ﹤0.01% 7994
2024
Q4 		$199K Sell
41,049
-34,729
-46% -$194K ﹤0.01% 10469
2024
Q3 		$585K Sell
75,778
-26,675
-26% -$237K ﹤0.01% 7931
2024
Q2 		$1.02M Buy
102,453
+50,252
+96% +$552K ﹤0.01% 6528
2024
Q1 		$634K Sell
52,201
-60,044
-53% -$871K ﹤0.01% 7863
2023
Q4 		$1.61M Buy
112,245
+59,206
+112% +$568K ﹤0.01% 5768
2023
Q3 		$413K Sell
53,039
-37,442
-41% -$407K ﹤0.01% 8495
2023
Q2 		$1.29M Sell
90,481
-98,104
-52% -$1.4M ﹤0.01% 5942
2023
Q1 		$2.76M Buy
188,585
+31,409
+20% +$526K ﹤0.01% 4779
2022
Q4 		$2.64M Buy
157,176
+58,498
+59% +$1.01M ﹤0.01% 4967
2022
Q3 		$1.46M Buy
+98,678
New +$1.95M ﹤0.01% 6204
2022
Q2 		– Sell
-52,488
Closed -$1.56M – 13753
2022
Q1 		$1.98M Buy
+52,488
New +$2.32M ﹤0.01% 6103
2021
Q4 		– Sell
-12,192
Closed -$924K – 14466
2021
Q3 		$1.04M Sell
12,192
-5,935
-33% -$372K ﹤0.01% 8049
2021
Q2 		$1.12M Buy
18,127
+11,103
+158% +$565K ﹤0.01% 8069
2021
Q1 		$342K Sell
7,024
-20,744
-75% -$1M ﹤0.01% 10538
2020
Q4 		$865K Buy
+27,768
New +$680K ﹤0.01% 7095

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Citadel Advisors's OPRX Position: Q2 2026 in Review

Citadel Advisors opened a new position in OptimizeRx (OPRX) in Q2 2026: 157,992 shares worth $904K. The stake represents ﹤0.01% of the portfolio and ranks #8453 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in OPRX as recently as Q4 2025.

Citadel Advisors first reported a position in OPRX in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.76M in Q1 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Citadel Advisors held 157,992 shares of OptimizeRx worth $904K as of Q2 2026.
  • OptimizeRx was a new Citadel Advisors position in Q2 2026.
  • OptimizeRx made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8453 holding.
  • Citadel Advisors first reported a position in OptimizeRx in Q4 2020 and has held it in 20 quarters since.
  • Citadel Advisors's OptimizeRx position peaked at $2.76M in Q1 2023.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.